Recent advances in systemic therapy for advanced intrahepatic cholangiocarcinoma
Background The incidence of intrahepatic cholangiocarcinoma (IHCCA) is rising around the world. The disease is becoming a major global health issue. Conventionally, most patients with cholangiocarcinoma present with advanced disease and systemic therapy is the mainstay of treatment. This review disc...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Karger Publishers
2023-06-01
|
Series: | Liver Cancer |
Online Access: | https://beta.karger.com/Article/FullText/531458 |